Lecture 54: Recombinant DNA and Cloning
Lecture 54: Recombinant DNA and Cloning
1
Restriction endonucleases
¾ Cleave DNA in a sequence-specific manner
¾ Evolved as a defense mechanism against infection by foreign
DNA
¾ Different restriction enzymes in different organisms
¾ Protect host DNA by modification-methylation
¾ Nomenclature: EcoRI
Digestion of DNA
¾ Digestion of a particular DNA gives specific, “invariant”
fragments of characteristic size
¾ Example: 3.2 Kbp DNA
700 bp 2000 bp 500 bp
5’--------ATGAATTCCA--------GCCGAATTCTTT---------3’
3’--------TACTTAAGGT--------GCCGTTAAGAAA--------5’
EcoRI
Restriction fragments of 2.0, 0.7, 0.5 Kbp
1900 bp
0 bp
CTAGAATTCTA
160 GATCTTAAGAT
4.1 Kbp AAAG
Circular DNA C
TTTC TTAAGA
GA
GCTG CT GAAT
TCT
G AC
GCG 600 bp
EcoRI
Restriction fragments of 1.9, 2.2 Kbp (Linear!)
2
Size-separation of DNA molecules and fragments by Electrophoresis
(+) (-)
C L
Circular + Linear
3
Restriction Mapping of a 6 Kbp linear DNA fragment
--digested with various restriction enzymes
23.1
9.4
6.0 5.4
6.5
4.4 3.5
3.9
3.5 3.3 3.3 3.3
2.8
2.5 2.5
2.3 2.1 2.1 2.1
1.9 2.0 2.0 2.0
2.0 1.9 1.4
1.4 1.4
0.6 0.6 0.6 0.7 0.7 0.7 0.7
0.5 0.6 0.5
PvuII/PstI
PstI
PstI/EcoRI
PstI/HinDIII
Uncut
PvuII/EcoRI
EcoRI
PvuII/HinDIII
HinDIII
HinDIII/EcoRI
PvuII
HindIII λ DNA
“marker”
mRNA
(Ethidium bromide staining)
Electrophoresis
Denature, blot
Blot
DNA probe
Radioautograph
4
DNA – Protein interactions
“Footprinting”
* *
5
Recombinant DNA and cloning
A. Introduction
“Cloning” is a way to isolate a specific DNA fragment (a “gene”) and
produce it in a pure form in large amounts. Cloning makes detailed
analysis possible that would otherwise be difficult or impossible without the
gene in pure form, separated from the rest of the DNA of the organism.
2. Steps in Cloning
a. Cut cloning vectors with a restriction
endonuclease
b. Cut out a piece of foreign DNA with the
same (or compatible) restriction
endonuclease
c. Join the foreign DNA to the vector using
DNA ligase
d. Introduce the recombinant vector into cells
(transfection, transformation) in which they
can replicate
e. Identify and isolate cells that contain the
recombinant vector. From these, other
cells (or clones) may be otained.
3. Cloning vectors
a. Bacterial plasmids: pBR 322, p SP6
b. Bacterial viruses: λ gt 11
c. Animal virsuses: SV40
4. Plasmids
a. Small circular ds DNA molecules
b. Contain genes for antibiotic resistance, to
allow selection by growth on media
containing (lacking) antibiotics
c. Contain several restriction sites
d. Can be replicated (amplified) in bacteria
6
5. Example: pBR322 (4362 bp)
Incorporation of foreign
DNA inactivates tetR gene
7
9. Isolation of cloned fragment
a. Concentrate bacteria with recombinant plasmid
b. Lyse
c. Differential precipitation of plasmid DNA
d. Cut out foreign DNA with Pst I or HindIII
e. Separate plasmid and foreign DNA on agarose gel
(+) (-)
HindIII or PstI
uncut
C. Expression of foreign genes in E. coli
1. Expression vectors
Vectors with a regulated bacterial promotor (eg β Gal) upstream from insertion site
Promoter transcription
5’ mRNA 3’
AAAAAAA
Anneal oligo (dT) primer
5’ AAAAAAA
3’ TTTTTTT 5’
Reverse transcriptase
mRNA
5’ AAAAAAA
3’ TTTTTTT
ss cDNA
8
mRNA
5’ AAAAAAA
3’ TTTTTTT
ss cDNA
ds cDNA
Other tricks
Can add tails (oligo C, G) with terminal transferase or add “linkers”
with ligase to facilitate coupling with vector DNA
Site-directed mutagenesis:
The ability to change individual
codons or groups of codons in
expressed coding sequences.
9
Applications of Recombinant DNA technologies
A. Construction of genetic “libraries” to assist in isolation / characterization of specific
genes and gene products:
cDNA libraries / expression libraries
genomic DNA libraries
cosmids
YAC’s (yeast artificial chromosomes)
Human Genome Project (and others…..)
B. Production of scarce proteins using expression vectors
C. Production of vaccines, hormones, blood clotting factors, etc.
D. Diagnostics: antibody and oligonucleotide probes:
cancer cells, detection / imaging
bacterial and viral diseases (Legionnaires, AIDS)
Prenatal diagnoses
Forensics
E. Therapeutics
Human insulin, Human growth hormone, interferons, growth factors, blood clotting
factors, Plasminogen activator, tumor necrosis factor, novel recombinant antibodies,
synthetic peptides as recombinant vaccines (Hep B, malaria, rabies, AIDS)
F. Gene Transfer
Plants---increased yield, improved tolerance, herbicide res., disease res.
Transgenic animals---production of scarce proteins (eg in cow’s milk), studies of
eukaryotic gene regulation
Human gene therapy
p. 150
10